They hand you a timeline, tell you to be patient, and leave it at that
These adverse reactions are generally mild to moderate and gradually alleviated in most patients (100, 104)
Importantly, 100% of participants receiving the 12 mg dose achieved at least 5% weight loss, while 91% achieved 10% or greater reduction, and 75% reached the clinically significant threshold of 15% weight loss
Cell 187(15):38293853 Wolfe MM, Boylan MO, Chin WW (2025) Glucose-dependent insulinotropic polypeptide in incretin physiology: role in health and disease
Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonist
These link to independently verified results and are accessible from product pages and the Astra Labs COA hub